Haploidentical Hematopoietic Cell Transplantation Using Post-transplant Cyclophosphamide for Children with Non-malignant Diseases - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34355352/
doi: 10.1007/s10875-021-01113-4. Online ahead of print. 1 Department of Pediatrics, Division of Pediatric Hematology and Oncology and Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan. [email protected]. 2 Department of...
Clinical Risk Factors and Prognostic Model for Idiopathic Inflammatory Demyelinating Diseases after Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34350623/
doi: 10.1002/ajh.26312. Online ahead of print. 1 Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China. 2 Collaborative Innovation Center of Hematology, Peking University, Beijing, China. 3 Beijing...
γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34335589/
Graft-versus-host disease (GVHD) is a pathology in which chemokines and their receptors play essential roles in directing the migration of alloreactive donor T cells into GVHD organs, thereby leading to...
CD26 expression on donor harvest as a risk predictive biomarker for developing Graft-versus-Host Disease post-Allogeneic Hematopoietic Stem Cell Transplantation: A tenyear followup study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34334382/
Total 23 healthy donors 28 years (13 males), and transplant recipients with median age 24 years (17 males) formed the study cohort. The diagnosis included malignant (n= 13) and non-malignant...
Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34343707/
This study aimed to analyse the efficacy of haploidentical donor (HID) haematopoietic stem cell transplantation as a first-line treatment for severe aplastic anaemia (SAA) with high-risk factors (infection or very...